Aducanumab is the first drug/therapy that has been approved by the FDA to treat Alzheimer’s disease. Clinical trials has displayed is effectiveness in reducing the accumulation beta-amyloid. Which leads to the cognitive and functional decline of the brain in patients…   Read more»